JNJ-10397049
Clinical data
ATC code
  • none
Identifiers
  • 1-(2,4-dibromophenyl)-3-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)urea
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC19H20Br2N2O3
Molar mass484.188 g·mol−1
3D model (JSmol)
  • BrC1=CC=C(NC(N[C@@H]2[C@H](C3=CC=CC=C3)OC(C)(C)OC2)=O)C(Br)=C1
  • InChI=1S/C19H20Br2N2O3/c1-19(2)25-11-16(17(26-19)12-6-4-3-5-7-12)23-18(24)22-15-9-8-13(20)10-14(15)21/h3-10,16-17H,11H2,1-2H3,(H2,22,23,24)/t16-,17-/m0/s1 ☒N
  • Key:RBKIJGLHFFQHBE-IRXDYDNUSA-N ☒N

JNJ-10397049 is a potent and highly selective OX2 receptor antagonist. In animals, JNJ-10397049 was found to have sleep-promoting effects and to attenuate the reinforcing effects of ethanol.[1][2]

References

  1. ↑ Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, et al. (July 2009). "Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat". The Journal of Pharmacology and Experimental Therapeutics. 330 (1): 142–51. doi:10.1124/jpet.109.152009. PMID 19363060. S2CID 5676758.
  2. ↑ Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, Morton K, et al. (May 2011). "Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement". Psychopharmacology. 215 (1): 191–203. doi:10.1007/s00213-010-2127-x. PMID 21181123. S2CID 28874886.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.